Potassium chloride and Otitis media - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Potassium Chloride?
Potassium chloride has active ingredients of potassium chloride. It is used in hypokalemia. Currently, eHealthMe is studying from 21,720 Potassium chloride users.
What is Otitis Media?
Otitis media (inflammation of the middle ear) is found to be associated with 1,358 drugs and 644 conditions by eHealthMe. Currently, we are studying 6,225 people who have Otitis media.
Do you take Potassium chloride and have Otitis media?Check whether Otitis media is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Potassium chloride side effects by duration, gender and age:
- Potassium chloride side effects (21,720 reports)
Otitis media treatments and more:
- Otitis media (6,225 reports)
All the drugs that are associated with Otitis media:
All the conditions that are associated with Otitis media:
How the study uses the data?
The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Potassium chloride) and Potassium chloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oxycodone and Communication Disorder - 2 seconds ago
- Ziprasidone Hydrochloride and Famciclovir drug interaction - 18 seconds ago
- Otezla and Acute Myeloid Leukaemia - 35 seconds ago
- Augmentin '125' and Shock Haemorrhagic - 36 seconds ago
- Armour Thyroid and Eating Disorder - 41 seconds ago
- Lanoxin and Methimazole drug interaction - a minute ago
- Evotaz and Wellbutrin drug interaction - a minute ago
- Hydroxyurea and Toviaz drug interaction - a minute ago
- Nubain and Vicoprofen drug interaction - a minute ago
- Midazolam Hydrochloride and Pancytopenia Aggravated - a minute ago